Prolight Diagnostics and TTP have developed the Point-of-Care system MicroFlex which brings the benefits of central-lab quality ELISA testing to more distributed environments with a compact and more user-friendly package.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 SEK | -12.16% | +98.17% | +7.97% |
Jun. 25 | Prolight Diagnostics and TTP Provides Update on MicroFlex Development | CI |
May. 17 | Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development | MT |
1st Jan change | Capi. | |
---|---|---|
+7.97% | 18.41M | |
-38.73% | 8.36B | |
+2.07% | 3.38B | |
-4.31% | 2.18B | |
-27.52% | 1.82B | |
-21.81% | 1.64B | |
+17.86% | 1.03B | |
+20.08% | 752M | |
-9.83% | 689M | |
-28.57% | 516M |
- Stock Market
- Equities
- PRLD Stock
- News Prolight Diagnostics AB
- Prolight Diagnostics and TTP Provides Update on MicroFlex Development